Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma ; volume:8 ; number:1 ; day:4 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (4.11.2020), 1-10, 12.2020
- Urheber
-
Fontanilles, Maxime
Marguet, Florent
Beaussire, Ludivine
Magne, Nicolas
Pépin, Louis-Ferdinand
Alexandru, Cristina
Tennevet, Isabelle
Hanzen, Chantal
Langlois, Olivier
Jardin, Fabrice
Laquerrière, Annie
Sarafan-Vasseur, Nasrin
Fiore, Fréderic Di
Clatot, Florian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-01057-7
- URN
-
urn:nbn:de:101:1-2020121719131858021299
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fontanilles, Maxime
- Marguet, Florent
- Beaussire, Ludivine
- Magne, Nicolas
- Pépin, Louis-Ferdinand
- Alexandru, Cristina
- Tennevet, Isabelle
- Hanzen, Chantal
- Langlois, Olivier
- Jardin, Fabrice
- Laquerrière, Annie
- Sarafan-Vasseur, Nasrin
- Fiore, Fréderic Di
- Clatot, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
Frequency of TERT Promoter Mutations in Prostate Cancer
hTERT Promoter-Mutationen in humanen Tumoren der Leber
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Human TERT promoter mutations as a prognostic biomarker in glioma
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
Frequency of TERT Promoter Mutations in Prostate Cancer
hTERT Promoter-Mutationen in humanen Tumoren der Leber
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Human TERT promoter mutations as a prognostic biomarker in glioma
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
Frequency of TERT Promoter Mutations in Prostate Cancer
hTERT Promoter-Mutationen in humanen Tumoren der Leber
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Human TERT promoter mutations as a prognostic biomarker in glioma
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma